Literature DB >> 9109729

Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus.

M A Vasef1, A Ferlito, L M Weiss.   

Abstract

Nasopharyngeal carcinoma (NPC) is an epithelial tumor with a distinct geographic distribution and characteristic histologic appearance. It is rare in Europe and North America, but it is among the most common cancers in southern China. Genetic predisposition, environmental factors, and Epstein-Barr virus (EBV) all have been associated with the pathogenesis of this tumor. There is an increasing body of evidence that among all these factors, EBV appears to be the strongest and most consistently related factor. According to the current sensitive in situ hybridization methods for the detection of EBV-encoded small RNAs (EBER), almost 100% of cases of NPC, irrespective of their histologic subtypes, have demonstrable EBERs in the nuclei of the tumor cells. In this review paper, we discuss the predisposing genetic and environmental factors and the role of EBV in the pathogenesis of this tumor with particular emphasis on the role of EBV.

Entities:  

Mesh:

Year:  1997        PMID: 9109729     DOI: 10.1177/000348949710600416

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  25 in total

1.  Nasopharyngeal carcinoma in a south European population: epidemiological data and clinical aspects in Portugal.

Authors:  Breda Eduardo; Catarino Raquel; Medeiros Rui
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-08       Impact factor: 2.503

2.  Second malignant tumors after treatment of nasopharyngeal carcinoma: four case reports and literature review.

Authors:  James P Malone; Roger J Levin
Journal:  Skull Base       Date:  2002-05

Review 3.  Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling.

Authors:  Robert Vander Broek; Grace E Snow; Zhong Chen; Carter Van Waes
Journal:  Oral Oncol       Date:  2013-10-28       Impact factor: 5.337

Review 4.  Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

Authors:  Josephine Chou; Yu-Ching Lin; Jae Kim; Liang You; Zhidong Xu; Biao He; David M Jablons
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

5.  Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.

Authors:  Mark D Sides; Gregory J Block; Bin Shan; Kyle C Esteves; Zhen Lin; Erik K Flemington; Joseph A Lasky
Journal:  Virology       Date:  2011-05-24       Impact factor: 3.616

Review 6.  Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems.

Authors:  John Kc Chan
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

7.  Significant associations between GSTM1/GSTT1 polymorphisms and nasopharyngeal cancer risk.

Authors:  Yumei Wei; Tao Zhou; Haiqun Lin; Mingping Sun; Dongqing Wang; Hongsheng Li; Baosheng Li
Journal:  Tumour Biol       Date:  2012-12-30

8.  Effect of Epstein-Barr virus infection on global gene expression in nasopharyngeal carcinoma.

Authors:  Yuan-Chii Gladys Lee; Yu-Chyi Hwang; Kuang-Chi Chen; Yong-Shiang Lin; Dah-Yeou Huang; Tao-Wei Huang; Cheng-Yan Kao; Han-Chung Wu; Chin-Tarng Lin; Chi-Ying F Huang
Journal:  Funct Integr Genomics       Date:  2006-09-19       Impact factor: 3.410

9.  Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients.

Authors:  Jiang Li; Hao-Yuan Mo; Geng Xiong; Lin Zhang; Jia He; Zhou-Feng Huang; Zhi-Wei Liu; Qiu-Yan Chen; Zi-Ming Du; Li-Min Zheng; Chao-Nan Qian; Yi-Xin Zeng
Journal:  J Biol Chem       Date:  2012-08-14       Impact factor: 5.157

10.  Deaths from nasopharyngeal cancer among waiters and waitresses in Chinese restaurants.

Authors:  Ignatius T S Yu; Yuk-lan Chiu; Tze-wai Wong; Jin-ling Tang
Journal:  Int Arch Occup Environ Health       Date:  2004-10-28       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.